CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 134 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $655,000 | -15.0% | 281,080 | +3.6% | 0.00% | 0.0% |
Q4 2017 | $771,000 | +15.2% | 271,306 | +16.1% | 0.00% | 0.0% |
Q3 2017 | $669,000 | +57.4% | 233,635 | +35.8% | 0.00% | – |
Q2 2017 | $425,000 | -51.5% | 172,033 | -29.2% | 0.00% | -100.0% |
Q1 2017 | $877,000 | +144.3% | 243,073 | +139.8% | 0.00% | – |
Q4 2016 | $359,000 | -61.7% | 101,384 | -56.4% | 0.00% | -100.0% |
Q3 2016 | $938,000 | -13.8% | 232,428 | -6.3% | 0.00% | 0.0% |
Q2 2016 | $1,088,000 | -41.5% | 247,957 | -49.6% | 0.00% | -50.0% |
Q1 2016 | $1,860,000 | -47.1% | 491,801 | +119.2% | 0.00% | -50.0% |
Q4 2015 | $3,519,000 | +98.1% | 224,395 | +33.2% | 0.00% | +100.0% |
Q3 2015 | $1,776,000 | -80.7% | 168,488 | -53.9% | 0.00% | -77.8% |
Q2 2015 | $9,215,000 | +15.5% | 365,408 | +27.7% | 0.01% | +12.5% |
Q1 2015 | $7,977,000 | +56.4% | 286,233 | +2.5% | 0.01% | +60.0% |
Q4 2014 | $5,099,000 | +88.4% | 279,356 | +33.8% | 0.01% | +150.0% |
Q3 2014 | $2,707,000 | +10.8% | 208,852 | +39.4% | 0.00% | 0.0% |
Q2 2014 | $2,444,000 | -44.0% | 149,795 | -39.4% | 0.00% | -50.0% |
Q1 2014 | $4,366,000 | +26.6% | 247,108 | +73.5% | 0.00% | +33.3% |
Q4 2013 | $3,449,000 | +63.3% | 142,453 | +138.9% | 0.00% | +50.0% |
Q3 2013 | $2,112,000 | +55.6% | 59,631 | -31.5% | 0.00% | +100.0% |
Q2 2013 | $1,357,000 | +0.1% | 87,014 | -25.7% | 0.00% | 0.0% |
Q1 2013 | $1,356,000 | – | 117,177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |